Latest Breaking News On - Plus sonrotoclax - Page 1 : comparemela.com

Nicole Lamanna, MD, discusses the results from the ongoing BGB-11417-101 study investigating combination zanubrutinib plus sonrotoclax in patients with treatment-naïve CLL/SLL.

Targeted therapiesB cell malignanciesPlus sonrotoclaxPatients with treatment naChronic lymphocytic leukemiaCll treatmentsChronic lymphocytic leukemia treatmentsBgb 11417 101Bcl2 inhibitor